IRIS PubliCatt

Lucchini, Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.386
EU - Europa 1.214
AS - Asia 257
AF - Africa 30
SA - Sud America 7
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.902
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.375
DE - Germania 345
SE - Svezia 341
IT - Italia 186
CN - Cina 125
IE - Irlanda 89
SG - Singapore 68
FR - Francia 60
GB - Regno Unito 40
UA - Ucraina 40
RU - Federazione Russa 34
IN - India 30
CI - Costa d'Avorio 26
FI - Finlandia 19
PL - Polonia 10
BE - Belgio 9
TR - Turchia 8
BR - Brasile 6
CA - Canada 6
RO - Romania 6
IR - Iran 5
NL - Olanda 5
ES - Italia 4
IL - Israele 4
JP - Giappone 4
AU - Australia 3
CH - Svizzera 3
CU - Cuba 3
DK - Danimarca 3
NZ - Nuova Zelanda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CZ - Repubblica Ceca 2
HK - Hong Kong 2
HU - Ungheria 2
IQ - Iraq 2
KR - Corea 2
MK - Macedonia 2
MX - Messico 2
NO - Norvegia 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
ZA - Sudafrica 2
AT - Austria 1
BN - Brunei Darussalam 1
CL - Cile 1
DZ - Algeria 1
EE - Estonia 1
GR - Grecia 1
KE - Kenya 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
MT - Malta 1
NP - Nepal 1
TH - Thailandia 1
VN - Vietnam 1
Totale 2.902
Salva come PNG Salva come JPEG
Città #
Chandler 418
Ashburn 138
Dublin 89
New York 70
San Mateo 55
Princeton 37
Wilmington 37
Beijing 36
Singapore 36
Boston 35
Rome 31
Nürnberg 30
Abidjan 26
Ann Arbor 25
Moscow 25
Redmond 22
Chicago 21
Jacksonville 18
Nanjing 18
Cattolica 17
Milan 17
Seattle 16
Fairfield 15
Pune 14
Marseille 13
Bremen 12
Norwalk 10
Helsinki 9
Houston 8
Lawrence 8
London 8
Woodbridge 8
Brussels 7
Dearborn 7
Florence 7
Redwood City 7
Andover 6
Leawood 6
Los Angeles 6
Bari 5
Boardman 5
Izmir 5
Lviv 5
Mountain View 5
Warsaw 5
Avon 4
Catania 4
Edinburgh 4
Jiaxing 4
Nanchang 4
Shenyang 4
São Paulo 4
Amsterdam 3
Augusta 3
Berlin 3
Brentonico 3
Busto Arsizio 3
Cambridge 3
Chiswick 3
Cologno Al Serio 3
Falls Church 3
Fuzhou 3
Guangzhou 3
Gunzenhausen 3
Havana 3
Hebei 3
Istanbul 3
Kish 3
Nibionno 3
Phoenix 3
Saint Louis 3
Septeme 3
Toronto 3
Washington 3
Zurich 3
Ansbach 2
Atlanta 2
Baotou 2
Bucharest 2
Budapest 2
Buffalo 2
Caldaro sulla Strada del Vino 2
Cerro Maggiore 2
Changchun 2
Chiavari 2
Clearwater 2
Denno 2
Erbil 2
Fremont 2
Hamilton 2
Hounslow 2
Kunming 2
Landshut 2
Lappeenranta 2
Lisbon 2
Lodz 2
Melbourne 2
Mexico City 2
Miami 2
Millbury 2
Totale 1.545
Salva come PNG Salva come JPEG
Nome #
Mutations in the 3' untranslated region of FUS causing FUS overexpression are associated with amyotrophic lateral sclerosis 259
Primary fibroblasts cultures reveal TDP-43 abnormalities in amyotrophic lateral sclerosis patients with and without SOD1 mutations 186
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 93
Mutations in the 3' untranslated region of FUS causing FUS overexpression are associated with amyotrophic lateral sclerosis 85
Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis 79
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 73
Oculopharyngeal muscular dystrophy: Clinical and neurophysiological features 70
Fingolimod vs dimethyl fumarate in multiple sclerosis 70
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 64
Long-term Follow-up and Muscle Imaging Findings in Brachio-Cervical Inflammatory Myopathy 64
Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients 64
Novel SEC61G-EGFR fusion gene in pediatric ependymomas discovered by clonal expansion of stem cells in absence of exogenous mitogens 62
Dominus effect: challenging complications of alemtuzumab-related thyroid autoimmunity 62
Defining the disease course of TNFα blockers-associated Multiple Sclerosis 61
Expression Profile of Long Non-Coding RNAs in Serum of Patients with Multiple Sclerosis. 60
A TLR/CD44 axis regulates T cell trafficking in experimental and human multiple sclerosis 59
Prognostic factors after treatment for iterative thymoma recurrences: A multicentric experience 58
Lower urinary tract disorders in multiple sclerosis patients: prevalence, clinical features, and response to treatments 56
A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients 54
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience 52
Severe dyspnoea with alteration of the diffusion capacity of the lung associated with fingolimod treatment 51
A unique case of multiphasic ADEM or what else? 50
The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review 49
Upper body involvement in GNE myopathy assessed by muscle imaging 49
Exit strategies for “needle fatigue” in multiple sclerosis: a propensity score-matched comparison study 48
Sativex® effects on promoter methylation and on CNR1/CNR2 expression in peripheral blood mononuclear cells of progressive multiple sclerosis patients 47
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study 46
Estimating the impact of COVID-19 pandemic on services provided by Italian Neuromuscular Centers: an Italian Association of Myology survey of the acute phase 46
Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients 45
Long-term Follow-up and Muscle Imaging Findings in Brachio-Cervical Inflammatory Myopathy 45
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 44
The Expanding Role of the Infectious Disease Expert in the Context of the MS Centre 44
Ixekizumab exposure associated with myelitis: A case report and a literature review 43
Liposome-based nanoparticles impact on regulatory and effector phenotypes of macrophages and T cells in multiple Sclerosis patients 42
Muscle biopsy features of idiopathic inflammatory myopathies and differential diagnosis 42
A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients 42
Anti-cN1A Antibodies Are Associated with More Severe Dysphagia in Sporadic Inclusion Body Myositis 42
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 41
Cyclophosphamide in highly aggressive Marburg-like multiple sclerosis 41
Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapies 41
Shift of multiple sclerosis onset towards older age 40
Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab 39
Muscle involvement in myasthenia gravis: Expanding the clinical spectrum of myasthenia-myositis association from a large cohort of patients 38
Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report 36
New onset of Susac syndrome after mRNA COVID-19 vaccine: a case report 35
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 35
Transient hair loss during treatment with dimethyl-fumarate for multiple sclerosis 25
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 23
Neurosarcoidosis presenting as longitudinally extensive myelitis: Diagnostic assessment, differential diagnosis, and therapeutic approach 21
CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis 20
Signs and symptoms of COVID-19 in patients with multiple sclerosis 19
Liposome-based nanoparticles impact on regulatory and effector phenotypes of macrophages and T cells in multiple Sclerosis patients 17
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study 16
Current Status of Oral Disease-Modifying Treatment Effects on Cognitive Outcomes in Multiple Sclerosis: A Scoping Review 15
Tumefactive Demyelinating Lesion Around a Developmental Venous Anomaly: A Rare Association 14
Serum-Circulating microRNAs in Sporadic Inclusion Body Myositis 12
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience 12
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study 10
NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab 10
COVID-19 presenting as a non-arteritic anterior ischemic optic neuropathy 9
New onset of Susac syndrome after mRNA COVID-19 vaccine: a case report 7
Multiple Sclerosis Onset before and after COVID-19 Vaccination: Can HLA Haplotype Be Determinant? 7
Totale 2.989
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.072
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.072
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020220 30 16 6 5 15 15 17 11 20 36 40 9
2020/2021168 7 9 1 11 13 6 9 18 15 24 40 15
2021/2022476 42 19 8 61 8 15 6 76 32 26 78 105
2022/20231.111 131 139 77 167 69 136 57 104 140 25 46 20
2023/2024630 23 146 26 37 16 110 44 52 10 21 68 77
2024/202518 18 0 0 0 0 0 0 0 0 0 0 0
Totale 2.989